Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Cook
Prognostic and Predictive Factors Associated With Ipilimumab-Related Adverse Events: A Retrospective Analysis of 11 NCI-sponsored Phase I Clinical Trials
Oncotarget
Oncology
Individual Differences in Neurobehavioral Effects of Pyridostigmine.
Related publications
The Generalizability of NCI-sponsored Clinical Trials Accrual Amongst Women With Gynecologic Malignancies
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Delayed Adverse Events in Phase I Trials of Molecularly Targeted and Cytotoxic Agents
Oncotarget
Oncology
Neurological Immune Related Adverse Events Associated With Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook
Journal of Clinical Medicine
Clinical Management of Adverse Events Associated With Lorlatinib
Oncologist
Cancer Research
Medicine
Oncology
Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
Gut and Liver
Hepatology
Gastroenterology
HLA-A*11:01 Is Associated With Levetiracetam-Induced Psychiatric Adverse Events
PLoS ONE
Multidisciplinary
Correction: Article on the Characterization and Multiparameter Analysis of Visual Adverse Events in Irofulven Single-Agent Phase I and II Trials
Clinical Cancer Research
Cancer Research
Oncology
Phase I Cancer Clinical Trials
British Journal of Cancer
Cancer Research
Oncology
Inappropriate Grading of Adverse Events in Cancer Clinical Trials—Reply
JAMA Oncology
Cancer Research
Oncology